ArticleNaunyn-Schmiedeberg's archives of pharmacology2026
Cutaneous adverse events associated with Rybrevant based on FDA adverse event reporting system (FAERS) database from 2021 to 2024.
Yuqin Zeng et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it